Literature DB >> 823155

Platelet glycocalicin. II. Purification and characterization.

I Okumura, C Lombart, G A Jamieson.   

Abstract

Glycocalicin, a major glycoprotein of the platelet glycocalyx, is obtained in soluble forms following platelet homogenization and has been purified to homogeneity. Glycalicin has a molecular weight of 148,000 (+/- 5,000) as determined by gel electrophoresis. It contains 60 grams % carbohydrate (46.6 mol %) comprising galactose, N-acetylgalactosamine, N-acetylglucosamine, and sialic acid as its principal sugars in a ratio of 2:1:1:2, but with a small amount of glucose (2.3 mol %), mannose (1.2 mol %), and fucose (1.9 mol %). The principal amino acids are serine and threonine (4.9 and 7.6 mol %), leucine (6.7 mol %), proline, (6.8 mol %), and aspartic and glutamic acids (4.7 and 5.8 mol %). Tryptic digestion of glycocalicin yielded a macroglycopeptide (Mr = 118,000 +/- 5,000) identical with that previously obtained from intact platelets (Pepper, D.S., and Jamieson, G.A. (1970) Biochemistry 9, 3706-3713) and a peptide of molecular weights 45,000 (+/- 2,000) which contained only 7 mol % carbohydrate. This peptide showed a significant enrichment of serine, glycine, and glutamic acids compared with glycocalicin and together these amino acids comprised over 50 mol % of the peptide. Purified glycocalicin gave a single precipitin line with antiserum prepared in chickens. It showed reactions of partial identity with both the macroglycopeptide and the (non-glyco)peptide obtained by tryptic digestion and these showed lines of partial identity with each other. These results suggest that at least three determinants are present in the intact molecule. Glycocalicin gave precipitin reactions with wheat germ agglutinin and with the lectin of Agaricus bisporus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823155

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets.

Authors:  Hassan Haji-Valizadeh; Christa L Modery-Pawlowski; Anirban Sen Gupta
Journal:  Nanoscale       Date:  2014-05-07       Impact factor: 7.790

2.  Distribution of glycoconjugates on the plasma membrane and on membranes of the open-canalicular system in human platelets. A cytochemical study.

Authors:  H Kawakami; H Hirano
Journal:  Histochemistry       Date:  1989

3.  Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib.

Authors:  J E Fox
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

4.  Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein.

Authors:  J A Lopez; D W Chung; K Fujikawa; F S Hagen; T Papayannopoulou; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Structural analysis of human platelet membrane glycoprotein I complex.

Authors:  R L Nachman; T Kinoshita; B Ferris
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor.

Authors:  H A Cooper; W P Bennett; G C White; R H Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.

Authors:  H A Cooper; K J Clemetson; E F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Stable expression in Chinese hamster ovary cells of a homogeneous recombinant active fragment of human platelet glycoprotein Ib alpha.

Authors:  B Schumpp-Vonach; G Kresbach; E J Schlaeger; B Steiner
Journal:  Cytotechnology       Date:  1995       Impact factor: 2.058

9.  Evidence that glycocalicin circulates in normal plasma.

Authors:  B S Coller; E Kalomiris; M Steinberg; L E Scudder
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

10.  Human platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins.

Authors:  M J Hickey; F S Hagen; M Yagi; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.